Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Neuropharmacology. 2016 Aug 11;110(Pt A):431–437. doi: 10.1016/j.neuropharm.2016.08.008

Figure 5. Systemic OX1R blockade did not alter saccharin-quinine consumption.

Figure 5

Paired t-tests showed that 3-mg/kg SB-334867 did not change saccharin-quinine (A) intake (t(1,11)=0.25, p=0.81) and (B) preference (t(1,17)=1.23, p=0.24) compared to vehicle. Data are shown as mean±SEM.